APA (7th ed.) Citation

P, L., S, M., S, M., D, M., G, C., A, S., & M, K. (2003). Urokinase-type plasminogen activator and insulin-like growth factor-binding protein 3 mRNA expression in endometriotic lesions and eutopic endometrium: Implications for the pathophysiology of endometriosis. Annals of the New York Academy of Sciences, 997, 223. https://doi.org/10.1196/annals.1290.025

Chicago Style (17th ed.) Citation

P, Lembessis, Milingos S, Michalas S, Milingos D, Creatsas G, Sourla A, and Koutsilieris M. "Urokinase-type Plasminogen Activator and Insulin-like Growth Factor-binding Protein 3 MRNA Expression in Endometriotic Lesions and Eutopic Endometrium: Implications for the Pathophysiology of Endometriosis." Annals of the New York Academy of Sciences 997 (2003): 223. https://doi.org/10.1196/annals.1290.025.

MLA (9th ed.) Citation

P, Lembessis, et al. "Urokinase-type Plasminogen Activator and Insulin-like Growth Factor-binding Protein 3 MRNA Expression in Endometriotic Lesions and Eutopic Endometrium: Implications for the Pathophysiology of Endometriosis." Annals of the New York Academy of Sciences, vol. 997, 2003, p. 223, https://doi.org/10.1196/annals.1290.025.